Search

Your search keyword '"Nicolau, Jose C."' showing total 34 results

Search Constraints

Start Over You searched for: Author "Nicolau, Jose C." Remove constraint Author: "Nicolau, Jose C." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
34 results on '"Nicolau, Jose C."'

Search Results

1. Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI

2. Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19

3. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

4. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

5. Abstract 13057: The Role of Ischemic and Bleeding Scores in Patients With Acute Coronary Syndromes Submitted to Coronary Surgical Revascularization During the Same Hospitalization

6. Abstract 12946: Among Patients With Acute Coronary Syndromes, is the Risk of Hyperglycemia for In-Hospital Mortality Similar in Men and Women?

7. Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial

8. Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial

10. Efficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection Fraction

11. Abstract 10481: The Effect of Current Smoking on Platelet Reactivity Measures by Point-of-Care Methods in Patients Treated With and Without Clopidogrel

13. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

14. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

15. Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial

16. The Impact of Sonothrombolysis on Left Ventricular Diastolic Function and Left Atrial Mechanics Preventing Left Atrial Remodeling in Patients With ST Elevation Acute Myocardial Infarction

17. MULTIVESSEL REVASCULARIZATION IN PATIENTS WITH DIABETES AND ACUTE CORONARY SYNDROMES

18. Multimorbidity, functional impairment, and mortality in older patients stable after prior acute myocardial infarction: Insights from the TIGRIS registry

19. INTERBLEED: Design of an International Study of Risk Factors for Gastrointestinal Bleeding and Cardiovascular Events After Gastrointestinal Bleeding

20. Long‐term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction

21. Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy

22. Effects of DPP4 Inhibitor in Platelet Reactivity and Other Cardiac Risk Markers in Patients with Type 2 Diabetes and Acute Myocardial Infarction

23. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial

24. Impact of sacubitril/valsartan compared to ramipril on cardiac structure and function\ud following acute myocardial infarction: The PARADISE-MI echocardiographic sub-study

25. Long‐term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction.

26. Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: Insights from the TIGRIS registry

27. Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA‐HF

28. Abstract 10724: Long-Term Mortality After Acute Coronary Syndromes Among Patients with Normal, Mid-Range or Low Ejection Fraction

29. Abstract 13782: Platelet Aggregation and Adenosine Levels Among Patients With Stable Chronic Coronary Artery Disease Taking Ticagrelor or Prasugrel

30. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

31. Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA-HF.

32. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

33. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction

34. Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.

Catalog

Books, media, physical & digital resources